SR Medical Technology Company Limited (HKG:0108)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.035
-0.225 (-9.96%)
Sep 10, 2026, 4:08 PM HKT

HKG:0108 Financials Overview

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
380.33327.91310.02352.64352.28331.34
Revenue Growth
15.98%5.77%-12.09%0.10%6.32%9.88%
Net Income
-182.33-109.63-918.5-129.31-320.13207.63
Earnings Per Share
-0.06-0.03-0.29-0.04-0.100.05
EPS Growth
-----26513.95%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Property Development and Investment
-140.98140.2148.02133.67126.18
Property Management
-186.94169.82204.62218.61205.15
Total
380.33327.91310.02352.64352.28331.34

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
118.86121.22193.15316.82360.68304.05
Total Debt
2,9582,8902,6532,6962,3862,166
Net Cash (Debt)
-2,839-2,769-2,460-2,379-2,025-1,862
Net Cash Growth
------
Net Cash Per Share
-0.88-0.86-0.76-0.74-0.63-0.41

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-121.7885.49122.57-106.3647.59
Free Cash Flow
-121.7885.49122.57-106.3647.59
Free Cash Flow Growth
-42.45%-30.25%--1142.53%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
4.24%19.88%23.98%39.66%35.62%5.80%
Pretax Margin
-54.90%-41.38%-312.08%-19.84%-94.89%40.18%
Profit Margin
-47.94%-33.43%-296.27%-36.67%-90.87%62.66%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----15.56
PS Ratio
17.7722.888.152.908.549.75